CA-RAHI-SYSTEMS
Rahi Systems has completed two new acquisitions that augment its Integrated Environment strategy, a holistic approach that encompasses all the devices and applications users interact with and the supporting technology behind the scenes. The acquisitions also expand Rahi’s ability to deliver highly efficient data center infrastructure solutions to customers worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190606005142/en/
Rahi’s acquisition of Serro LLC brings additional expertise in network design, automation, orchestration and cloud infrastructure. The Serro team provides consulting and implementation services and 24x7 managed services through its Network Operations Center in Fremont, California. Its bill-of-materials creation and validation, order management, staging, integration and delivery services complement and enhance Rahi’s global distribution and logistics capabilities.
“The network is a key component of our Integrated Environment offering. The ability to architect the right network brings real business benefits to our customers, including increased efficiency, productivity and resilience,” said Tarun Raisoni, CEO & Co-Founder, Rahi Systems. “Serro has a team of talented engineers who can deliver this unique value to our customers. We are very excited to expand upon our ability to build secure, reliable and scalable networks.”
Australia-based PiTek offers unique data center solutions for raised floors, structural ceilings, electrical distribution busways and airflow management, along with racks, cabinets and aisle-containment products. PiTek founder Tony Khoury is now General Manager for Rahi Systems Australia, helping to build Rahi’s presence in the fast-growing region.
“Tony has more than 30 years of experience in the data center industry, and he and his team will help us deliver infrastructure solutions more efficiently so that our customers can get to market faster,” Raisoni said. “PiTek’s solutions will complement our current offering of racks, cabinets, cooling units, cabling, components and accessories, enabling us to bring a broader array of solutions to customers around the world.”
To gain more insight on Rahi Systems business vision, and to learn more about recent acquisitions watch Rahi Updates .
About Rahi Systems
Rahi Systems delivers a suite of solutions and services that optimizes the cost, performance, scalability, manageability and efficiency of today’s integrated environment. Founded in 2012 by entrepreneurs with deep understanding of the needs and challenges of service providers, government agencies and enterprises, the company has grown through a solutions-oriented approach, outstanding support and a culture of customer success. Rahi has its corporate headquarters in Fremont, Calif., with offices in the U.S., India, Hong Kong, Singapore, China, Turkey, Ireland, the Netherlands, the United Kingdom, Japan and Australia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005142/en/
Contact:
Media Contact: Alison Lolis VP of Marketing 510.651.2205 alison@rahisystems.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom